Back to All Events Advances in motion highlights our identification of stathmin-2 as a novel therapeutic target in TDP43-mediated ALS/FTD Thursday, January 17, 2019 7:00 PM 8:00 PM Google Calendar ICS https://advances.massgeneral.org/neuro/journal.aspx?id=1188 Previous Previous January 14 Melamed et al. is published in Nature Neuroscience Next Next January 18 Alzforum highlights the manuscripts Melamed et al. and Klim et al. identifying TDP-43 mediated loss of Stathmin-2 in ALS
Advances in motion highlights our identification of stathmin-2 as a novel therapeutic target in TDP43-mediated ALS/FTD Thursday, January 17, 2019 7:00 PM 8:00 PM Google Calendar ICS https://advances.massgeneral.org/neuro/journal.aspx?id=1188